Logo image of LGCB

LINKAGE GLOBAL INC (LGCB) Stock Fundamental Analysis

NASDAQ:LGCB - KYG5500B1288 - Common Stock

2.23 USD
-0.03 (-1.32%)
Last: 8/29/2025, 8:00:02 PM
Fundamental Rating

2

LGCB gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 28 industry peers in the Broadline Retail industry. While LGCB seems to be doing ok healthwise, there are quite some concerns on its profitability. LGCB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

LGCB had negative earnings in the past year.
LGCB had a negative operating cash flow in the past year.
LGCB Yearly Net Income VS EBIT VS OCF VS FCFLGCB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1M -1M -2M -3M

1.2 Ratios

With a Return On Assets value of -3.46%, LGCB is not doing good in the industry: 67.86% of the companies in the same industry are doing better.
The Return On Equity of LGCB (-6.25%) is worse than 60.71% of its industry peers.
Industry RankSector Rank
ROA -3.46%
ROE -6.25%
ROIC N/A
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)4.69%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LGCB Yearly ROA, ROE, ROICLGCB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 10 -10 20 30

1.3 Margins

The Gross Margin of LGCB (40.49%) is comparable to the rest of the industry.
LGCB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LGCB Yearly Profit, Operating, Gross MarginsLGCB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 10 20 30 40

More info and screens

6

2. Health

2.1 Basic Checks

LGCB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LGCB has more shares outstanding
Compared to 1 year ago, LGCB has an improved debt to assets ratio.
LGCB Yearly Shares OutstandingLGCB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 500K 1M 1.5M 2M
LGCB Yearly Total Debt VS Total AssetsLGCB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

LGCB has an Altman-Z score of 3.50. This indicates that LGCB is financially healthy and has little risk of bankruptcy at the moment.
LGCB's Altman-Z score of 3.50 is fine compared to the rest of the industry. LGCB outperforms 64.29% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that LGCB is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.26, LGCB is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 3.5
ROIC/WACCN/A
WACC6.17%
LGCB Yearly LT Debt VS Equity VS FCFLGCB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

LGCB has a Current Ratio of 2.73. This indicates that LGCB is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.73, LGCB belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
A Quick Ratio of 2.71 indicates that LGCB has no problem at all paying its short term obligations.
LGCB has a better Quick ratio (2.71) than 92.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.71
LGCB Yearly Current Assets VS Current LiabilitesLGCB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

LGCB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.43%, which is quite impressive.
Looking at the last year, LGCB shows a very negative growth in Revenue. The Revenue has decreased by -19.19% in the last year.
EPS 1Y (TTM)36.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%165.38%
Revenue 1Y (TTM)-19.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-56.87%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LGCB Yearly Revenue VS EstimatesLGCB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 5M 10M 15M 20M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LGCB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LGCB Price Earnings VS Forward Price EarningsLGCB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

75.00% of the companies in the same industry are cheaper than LGCB, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 69.84
LGCB Per share dataLGCB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LGCB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LINKAGE GLOBAL INC

NASDAQ:LGCB (8/29/2025, 8:00:02 PM)

2.23

-0.03 (-1.32%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.2%
Inst Owner ChangeN/A
Ins Owners82.06%
Ins Owner ChangeN/A
Market Cap16.90M
AnalystsN/A
Price TargetN/A
Short Float %4.01%
Short Ratio6.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.64
P/FCF N/A
P/OCF N/A
P/B 2.41
P/tB 2.41
EV/EBITDA 69.84
EPS(TTM)-0.21
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS1.36
BVpS0.93
TBVpS0.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.46%
ROE -6.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.49%
FCFM N/A
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)4.69%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 7.82
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 2.71
Altman-Z 3.5
F-Score4
WACC6.17%
ROIC/WACCN/A
Cap/Depr(3y)198.18%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.76%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%165.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-56.87%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y89.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.89%
OCF growth 3YN/A
OCF growth 5YN/A